9:11 AM ET
8-K
M&A Deal
Biolife Solutions M&A Deal with Repligen Corporation
BioLife Solutions completed its merger with Repligen Corporation, becoming a wholly owned subsidiary of Repligen. BioLife stockholders received 0.1442 shares of Repligen common stock and $11.25 in cash for each share of BioLife common stock held. As a result of the completion, BioLife's common stock will be delisted from the Nasdaq Stock Market.
- Counterparty
- Repligen Corporation